Stay updated on SKI-G-801 Dose Study in AML Clinical Trial
Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.

Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check14 days agoChange DetectedThe two screenshots reflect the same study record without changes to core content such as study title, conditions, interventions, eligibility criteria, or outcome measures.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a new revision tag v3.4.2 and removed an outdated funding-status notice (and the earlier v3.4.1 revision).SummaryDifference0.5%

- Check43 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and where to check status, and updated the page revision to v3.4.1 (removing v3.4.0).SummaryDifference0.5%

- Check50 days agoChange DetectedAdded a Show glossary option and a new 'Last Update Submitted that Met QC Criteria' field. Updated capitalization of 'Last Update Submitted that met QC Criteria', standardized 'No FEAR Act Data' wording, and bumped the revision from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check64 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page, reflecting a version bump. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.